Ann M. Veneman, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 1,670 shares at $145.81 ($244K) on 2017-09-05, disclosed to the SEC on 2017-09-05.
Open-market sale of $244k ALXN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $145.81 | 835 | $122K | 50.0% |
| 2 | $145.81 | 835 | $122K | 50.0% |
| Total | $145.81 avg | 1,670 | $244K | 100% |
| Filing → |
| ALXN | SELL | 2014-12-15 | $238K | — | Filing → |
| ALXN | SELL | 2014-06-06 | $210K | — | Filing → |
| ALXN | SELL | 2013-05-01 | $308K | — | Filing → |